Trial reportInternational urology and nephrology2026
Comparison of augmented prophylaxis using intra-prostatic antibiotic injection with standard oral prophylaxis in preventing the infectious complications following trans-rectal ultrasound (TRUS)-guided prostatic biopsy: a randomized controlled study.
Trial report in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGlobally, infective complications following TRUS-guided biopsies along with emerging fluoroquinolone-resistant bacterial strains are a growing concern. Lack of specific guidelines on this subject necessitates the need to explore potential strategies to prevent such complications. Intra-prostatic antibiotic administered during TRUS is evaluated as an effective strategy to minimize infections with minimal systemic adverse effects.
objectiveTo compare the efficacy of Augmented Prophylaxis using combined single dose intra-prostatic antibiotic injection and oral prophylactic antibiotic with standard oral prophylactic antibiotic to prevent urinary tract infections(UTI) and its associated complications in patients undergoing TRUS Guided Prostatic Biopsy.
methodsWe have included one hundred and ninety consecutive consenting patients for TRUS guided prostate biopsy for diagnosis of prostate cancer between July 2021 and January 2024, they were randomized into 2 groups-first group, receiving intra-prostatic injection of amikacin with oral ciprofloxacin (group 'T') and second group receiving only oral ciprofloxacin (group 'C'). The incidence of urinary tract infections and associated complications during a 7-day follow-up was assessed among the two groups.
resultsNinety-five patients were assigned to each of the groups 'T' and 'C.' We observed that there were statistically significantly lower UTI rates in group 'T' compared to group 'C' (1.25 vs 12.63%, p = 0.002). Additionally, Group 'T' exhibited A lower incidence of post-biopsy complications like sepsis and LUTS.
conclusionIntra-prostatic antibiotic is an effective adjunct to Oral antibiotic as a prophylaxis to prevent post-TURS urinary tract infectious complications.
Indexed as
Identifiers
40796678What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.